Golino M, Harding D, Del Buono M, Fanti S, Mohiddin S, Toldo S
Int J Cardiol. 2024; 404:131901.
PMID: 38403204
PMC: 11450758.
DOI: 10.1016/j.ijcard.2024.131901.
Zhang H, Dhalla N
Int J Mol Sci. 2024; 25(2).
PMID: 38256155
PMC: 10817020.
DOI: 10.3390/ijms25021082.
Fairweather D, Beetler D, Di Florio D, Musigk N, Heidecker B, Cooper Jr L
Circ Res. 2023; 132(10):1302-1319.
PMID: 37167363
PMC: 10171304.
DOI: 10.1161/CIRCRESAHA.123.321878.
Hamedi K, Loftus G, Traylor L, Goodwin R, Arce S
Vaccines (Basel). 2023; 11(2).
PMID: 36851240
PMC: 9967770.
DOI: 10.3390/vaccines11020362.
Luca G, Cavalli G, Campochiaro C, Bruni C, Tomelleri A, Dagna L
Front Immunol. 2021; 12:653950.
PMID: 33833766
PMC: 8021854.
DOI: 10.3389/fimmu.2021.653950.
Haploinsufficient and Mice Are Not Protected from Cardiac Inflammation and Postinflammatory Fibrosis in Experimental Autoimmune Myocarditis.
Tkacz K, Rolski F, Czepiel M, Dzialo E, Siedlar M, Eriksson U
Cells. 2020; 9(3).
PMID: 32178482
PMC: 7140701.
DOI: 10.3390/cells9030700.
Inhibition of microRNA-15 protects H9c2 cells against CVB3-induced myocardial injury by targeting NLRX1 to regulate the NLRP3 inflammasome.
Tong R, Jia T, Shi R, Yan F
Cell Mol Biol Lett. 2020; 25:6.
PMID: 32099552
PMC: 7031959.
DOI: 10.1186/s11658-020-00203-2.
Myocarditis: An Interleukin-1-Mediated Disease?.
Luca G, Cavalli G, Campochiaro C, Tresoldi M, Dagna L
Front Immunol. 2018; 9:1335.
PMID: 29951067
PMC: 6008311.
DOI: 10.3389/fimmu.2018.01335.
Pathways involved in interleukin-1β-mediated murine cardiomyocyte apoptosis.
Shen Y, Qin J, Bu P
Tex Heart Inst J. 2015; 42(2):109-16.
PMID: 25873819
PMC: 4382874.
DOI: 10.14503/THIJ-14-4254.
Quality control systems in cardiac aging.
Quarles E, Dai D, Tocchi A, Basisty N, Gitari L, Rabinovitch P
Ageing Res Rev. 2015; 23(Pt A):101-15.
PMID: 25702865
PMC: 4686341.
DOI: 10.1016/j.arr.2015.02.003.
Cytokine production associated with smallpox vaccine responses.
Simon W, Salk H, Ovsyannikova I, Kennedy R, Poland G
Immunotherapy. 2014; 6(10):1097-112.
PMID: 25428648
PMC: 4263415.
DOI: 10.2217/imt.14.72.
Targeting interleukin-1 in heart failure and inflammatory heart disease.
Van Tassell B, Valle Raleigh J, Abbate A
Curr Heart Fail Rep. 2014; 12(1):33-41.
PMID: 25315037
DOI: 10.1007/s11897-014-0231-7.
Treatment with N-acetyl-seryl-aspartyl-lysyl-proline prevents experimental autoimmune myocarditis in rats.
Nakagawa P, Liu Y, Liao T, Chen X, Gonzalez G, Bobbitt K
Am J Physiol Heart Circ Physiol. 2012; 303(9):H1114-27.
PMID: 22923621
PMC: 3517643.
DOI: 10.1152/ajpheart.00300.2011.
Induction of a broad spectrum of inflammation-related genes by Coxsackievirus B3 requires Interleukin-1 signaling.
Rehren F, Ritter B, Dittrich-Breiholz O, Henke A, Lam E, Kati S
Med Microbiol Immunol. 2012; 202(1):11-23.
PMID: 22661216
DOI: 10.1007/s00430-012-0245-2.
IL-33 independently induces eosinophilic pericarditis and cardiac dilation: ST2 improves cardiac function.
Abston E, Barin J, cihakova D, Bucek A, Coronado M, Brandt J
Circ Heart Fail. 2012; 5(3):366-75.
PMID: 22454393
PMC: 3874395.
DOI: 10.1161/CIRCHEARTFAILURE.111.963769.
Critical cytokine pathways to cardiac inflammation.
Rose N
J Interferon Cytokine Res. 2011; 31(10):705-10.
PMID: 21861699
PMC: 3189548.
DOI: 10.1089/jir.2011.0057.
Proinflammatory cytokines in heart failure: double-edged swords.
Hedayat M, Mahmoudi M, Rose N, Rezaei N
Heart Fail Rev. 2010; 15(6):543-62.
PMID: 20405319
DOI: 10.1007/s10741-010-9168-4.
Myocarditis: infection versus autoimmunity.
Rose N
J Clin Immunol. 2009; 29(6):730-7.
PMID: 19826933
DOI: 10.1007/s10875-009-9339-z.
The role of IL-1 in the pathogenesis of heart disease.
Bujak M, Frangogiannis N
Arch Immunol Ther Exp (Warsz). 2009; 57(3):165-76.
PMID: 19479203
PMC: 2788964.
DOI: 10.1007/s00005-009-0024-y.
Coxsackievirus B3-induced myocarditis: infection of females during the estrus phase of the ovarian cycle leads to activation of T regulatory cells.
Huber S
Virology. 2008; 378(2):292-8.
PMID: 18586295
PMC: 2596296.
DOI: 10.1016/j.virol.2008.05.015.